The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nasal Spray Live Attenuated Vaccine Market Research Report 2025
Synopsis
Nasal spray live attenuated vaccine is a live attenuated viral vaccine administered by nasal spray for the prevention of infection against specific diseases. This vaccine injects a weakened live virus into the body through the nasal mucosal route, which activates the immune system to produce a protective immune response against the disease.
The global Nasal Spray Live Attenuated Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Nasal Spray Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nasal Spray Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nasal Spray Live Attenuated Vaccine include AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., Changchun BCHT Biotechnology Co., Serum Institute, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nasal Spray Live Attenuated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Spray Live Attenuated Vaccine.
The Nasal Spray Live Attenuated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Nasal Spray Live Attenuated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nasal Spray Live Attenuated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca
Sanofi
CSL
BioDiem
SEQIRUS, INC.
Changchun BCHT Biotechnology Co.
Serum Institute
Segment by Type
Trivalent Nasal Spray Live Attenuated Vaccine
Quadrivalent Nasal Spray Live Attenuated Vaccine
Segment by Application
Hospitals & Clinics
Public Health Organizations
Research Organizations
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nasal Spray Live Attenuated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nasal Spray Live Attenuated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nasal spray live attenuated vaccine is a live attenuated viral vaccine administered by nasal spray for the prevention of infection against specific diseases. This vaccine injects a weakened live virus into the body through the nasal mucosal route, which activates the immune system to produce a protective immune response against the disease.
The global Nasal Spray Live Attenuated Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Nasal Spray Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nasal Spray Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nasal Spray Live Attenuated Vaccine include AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., Changchun BCHT Biotechnology Co., Serum Institute, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nasal Spray Live Attenuated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Spray Live Attenuated Vaccine.
The Nasal Spray Live Attenuated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Nasal Spray Live Attenuated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nasal Spray Live Attenuated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca
Sanofi
CSL
BioDiem
SEQIRUS, INC.
Changchun BCHT Biotechnology Co.
Serum Institute
Segment by Type
Trivalent Nasal Spray Live Attenuated Vaccine
Quadrivalent Nasal Spray Live Attenuated Vaccine
Segment by Application
Hospitals & Clinics
Public Health Organizations
Research Organizations
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nasal Spray Live Attenuated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nasal Spray Live Attenuated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nasal Spray Live Attenuated Vaccine Market Overview
1.1 Product Definition
1.2 Nasal Spray Live Attenuated Vaccine by Type
1.2.1 Global Nasal Spray Live Attenuated Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Nasal Spray Live Attenuated Vaccine
1.2.3 Quadrivalent Nasal Spray Live Attenuated Vaccine
1.3 Nasal Spray Live Attenuated Vaccine by Application
1.3.1 Global Nasal Spray Live Attenuated Vaccine Market Value by Application (2024-2030)
1.3.2 Hospitals & Clinics
1.3.3 Public Health Organizations
1.3.4 Research Organizations
1.3.5 Others
1.4 Global Nasal Spray Live Attenuated Vaccine Market Size Estimates and Forecasts
1.4.1 Global Nasal Spray Live Attenuated Vaccine Revenue 2019-2030
1.4.2 Global Nasal Spray Live Attenuated Vaccine Sales 2019-2030
1.4.3 Global Nasal Spray Live Attenuated Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nasal Spray Live Attenuated Vaccine Market Competition by Manufacturers
2.1 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nasal Spray Live Attenuated Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Nasal Spray Live Attenuated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Date of Enter into This Industry
2.8 Global Nasal Spray Live Attenuated Vaccine Market Competitive Situation and Trends
2.8.1 Global Nasal Spray Live Attenuated Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nasal Spray Live Attenuated Vaccine Players Market Share by Revenue
2.8.3 Global Nasal Spray Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nasal Spray Live Attenuated Vaccine Market Scenario by Region
3.1 Global Nasal Spray Live Attenuated Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nasal Spray Live Attenuated Vaccine Sales by Region: 2019-2030
3.2.1 Global Nasal Spray Live Attenuated Vaccine Sales by Region: 2019-2024
3.2.2 Global Nasal Spray Live Attenuated Vaccine Sales by Region: 2025-2030
3.3 Global Nasal Spray Live Attenuated Vaccine Revenue by Region: 2019-2030
3.3.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Region: 2019-2024
3.3.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Region: 2025-2030
3.4 North America Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.4.1 North America Nasal Spray Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2030)
3.4.3 North America Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.5.1 Europe Nasal Spray Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2030)
3.5.3 Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Nasal Spray Live Attenuated Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.7.1 Latin America Nasal Spray Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nasal Spray Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2030)
4.1.1 Global Nasal Spray Live Attenuated Vaccine Sales by Type (2019-2024)
4.1.2 Global Nasal Spray Live Attenuated Vaccine Sales by Type (2025-2030)
4.1.3 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2019-2030)
4.2.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2019-2024)
4.2.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2025-2030)
4.2.3 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Nasal Spray Live Attenuated Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2030)
5.1.1 Global Nasal Spray Live Attenuated Vaccine Sales by Application (2019-2024)
5.1.2 Global Nasal Spray Live Attenuated Vaccine Sales by Application (2025-2030)
5.1.3 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2019-2030)
5.2.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2019-2024)
5.2.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2025-2030)
5.2.3 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Nasal Spray Live Attenuated Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Nasal Spray Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Nasal Spray Live Attenuated Vaccine Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Nasal Spray Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Nasal Spray Live Attenuated Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Nasal Spray Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Nasal Spray Live Attenuated Vaccine Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 BioDiem
6.4.1 BioDiem Company Information
6.4.2 BioDiem Description and Business Overview
6.4.3 BioDiem Nasal Spray Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioDiem Nasal Spray Live Attenuated Vaccine Product Portfolio
6.4.5 BioDiem Recent Developments/Updates
6.5 SEQIRUS, INC.
6.5.1 SEQIRUS, INC. Company Information
6.5.2 SEQIRUS, INC. Description and Business Overview
6.5.3 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product Portfolio
6.5.5 SEQIRUS, INC. Recent Developments/Updates
6.6 Changchun BCHT Biotechnology Co.
6.6.1 Changchun BCHT Biotechnology Co. Company Information
6.6.2 Changchun BCHT Biotechnology Co. Description and Business Overview
6.6.3 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product Portfolio
6.6.5 Changchun BCHT Biotechnology Co. Recent Developments/Updates
6.7 Serum Institute
6.7.1 Serum Institute Company Information
6.7.2 Serum Institute Description and Business Overview
6.7.3 Serum Institute Nasal Spray Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Serum Institute Nasal Spray Live Attenuated Vaccine Product Portfolio
6.7.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nasal Spray Live Attenuated Vaccine Industry Chain Analysis
7.2 Nasal Spray Live Attenuated Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nasal Spray Live Attenuated Vaccine Production Mode & Process
7.4 Nasal Spray Live Attenuated Vaccine Sales and Marketing
7.4.1 Nasal Spray Live Attenuated Vaccine Sales Channels
7.4.2 Nasal Spray Live Attenuated Vaccine Distributors
7.5 Nasal Spray Live Attenuated Vaccine Customers
8 Nasal Spray Live Attenuated Vaccine Market Dynamics
8.1 Nasal Spray Live Attenuated Vaccine Industry Trends
8.2 Nasal Spray Live Attenuated Vaccine Market Drivers
8.3 Nasal Spray Live Attenuated Vaccine Market Challenges
8.4 Nasal Spray Live Attenuated Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nasal Spray Live Attenuated Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nasal Spray Live Attenuated Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Nasal Spray Live Attenuated Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nasal Spray Live Attenuated Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nasal Spray Live Attenuated Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nasal Spray Live Attenuated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nasal Spray Live Attenuated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Spray Live Attenuated Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nasal Spray Live Attenuated Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nasal Spray Live Attenuated Vaccine Sales by Region (2019-2024) & (K Dose)
Table 18. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Nasal Spray Live Attenuated Vaccine Sales by Region (2025-2030) & (K Dose)
Table 20. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Nasal Spray Live Attenuated Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Nasal Spray Live Attenuated Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Nasal Spray Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 27. North America Nasal Spray Live Attenuated Vaccine Sales by Country (2025-2030) & (K Dose)
Table 28. North America Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nasal Spray Live Attenuated Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Type (2019-2024)
Table 51. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Type (2025-2030)
Table 52. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2019-2024)
Table 59. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2025-2030)
Table 60. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Application (2019-2024)
Table 61. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Application (2025-2030)
Table 62. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2019-2024)
Table 69. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2025-2030)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. AstraZeneca Nasal Spray Live Attenuated Vaccine Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Sanofi Nasal Spray Live Attenuated Vaccine Product
Table 79. Sanofi Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. CSL Nasal Spray Live Attenuated Vaccine Product
Table 84. CSL Recent Developments/Updates
Table 85. BioDiem Company Information
Table 86. BioDiem Description and Business Overview
Table 87. BioDiem Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. BioDiem Nasal Spray Live Attenuated Vaccine Product
Table 89. BioDiem Recent Developments/Updates
Table 90. SEQIRUS, INC. Company Information
Table 91. SEQIRUS, INC. Description and Business Overview
Table 92. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product
Table 94. SEQIRUS, INC. Recent Developments/Updates
Table 95. Changchun BCHT Biotechnology Co. Company Information
Table 96. Changchun BCHT Biotechnology Co. Description and Business Overview
Table 97. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product
Table 99. Changchun BCHT Biotechnology Co. Recent Developments/Updates
Table 100. Serum Institute Company Information
Table 101. Serum Institute Description and Business Overview
Table 102. Serum Institute Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Serum Institute Nasal Spray Live Attenuated Vaccine Product
Table 104. Serum Institute Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Nasal Spray Live Attenuated Vaccine Distributors List
Table 108. Nasal Spray Live Attenuated Vaccine Customers List
Table 109. Nasal Spray Live Attenuated Vaccine Market Trends
Table 110. Nasal Spray Live Attenuated Vaccine Market Drivers
Table 111. Nasal Spray Live Attenuated Vaccine Market Challenges
Table 112. Nasal Spray Live Attenuated Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nasal Spray Live Attenuated Vaccine
Figure 2. Global Nasal Spray Live Attenuated Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nasal Spray Live Attenuated Vaccine Market Share by Type: 2023 & 2030
Figure 4. Trivalent Nasal Spray Live Attenuated Vaccine Product Picture
Figure 5. Quadrivalent Nasal Spray Live Attenuated Vaccine Product Picture
Figure 6. Global Nasal Spray Live Attenuated Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Nasal Spray Live Attenuated Vaccine Market Share by Application: 2023 & 2030
Figure 8. Hospitals & Clinics
Figure 9. Public Health Organizations
Figure 10. Research Organizations
Figure 11. Others
Figure 12. Global Nasal Spray Live Attenuated Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Nasal Spray Live Attenuated Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Nasal Spray Live Attenuated Vaccine Sales (2019-2030) & (K Dose)
Figure 15. Global Nasal Spray Live Attenuated Vaccine Average Price (US$/Dose) & (2019-2030)
Figure 16. Nasal Spray Live Attenuated Vaccine Report Years Considered
Figure 17. Nasal Spray Live Attenuated Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Nasal Spray Live Attenuated Vaccine Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Nasal Spray Live Attenuated Vaccine Players: Market Share by Revenue in Nasal Spray Live Attenuated Vaccine in 2023
Figure 20. Nasal Spray Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Nasal Spray Live Attenuated Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. United States Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Mexico Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Nasal Spray Live Attenuated Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Nasal Spray Live Attenuated Vaccine by Type (2019-2030)
Figure 54. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2019-2030)
Figure 55. Global Sales Market Share of Nasal Spray Live Attenuated Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Nasal Spray Live Attenuated Vaccine by Application (2019-2030)
Figure 57. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2019-2030)
Figure 58. Nasal Spray Live Attenuated Vaccine Value Chain
Figure 59. Nasal Spray Live Attenuated Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
